Annual report pursuant to Section 13 and 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)

v3.22.2.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
12 Months Ended
May 31, 2022
May 31, 2021
May 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]      
Cash and Cash Equivalents, at Carrying Value $ 2,551,859 $ 1,665,263 $ 2,925,568
Accounts Receivable, Credit Loss Expense (Reversal) 79,847 15,798  
Goodwill 557,896 557,896  
Net Income (Loss) Attributable to Noncontrolling Interest (97,211) 0  
Advertising Expense 1,453,727 1,237,326  
Research and Development Expense $ 17,361 $ 37,122  
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) 75,306,426 129,623,809  
Goodwill, Impairment Loss   $ 25,185,003  
Warrant [Member]      
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) 6,451,339 53,997,645  
Equity Unit Purchase Agreements [Member]      
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) 3,041,290 7,676,974  
Convertible Debt Securities [Member]      
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) 65,693,797 67,106,559  
Stock Payable [Member]      
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares) 120,000 70,000